Potential benefits and limitations of various strategies to mitigate the impact of an influenza pandemic

Journal of Infection and Chemotherapy

Volumn 12, Issue 4, 2006, Pages 167-171

  Oshitani, Hitoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Influenza; Mitigating strategy; Pandemic

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

EPIDEMIC; INFECTION CONTROL; INFLUENZA; MORBIDITY; MORTALITY; PERSONAL HYGIENE; REVIEW; SOCIAL DISTANCE;

EID: 33748299179     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-006-0453-z     Document Type: Review

References (47)

1. JS Nguyen-Van-Tam AW Hampson 2003 The epidemiology and clinical impact of pandemic influenza Vaccine 21 1762 8
2. KL Nichol 2003 The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines Vaccine 21 1769 75
3. JM Langley ME Faughnan 2004 Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care CMAJ 171 1169 70
4. AS Monto 2006 Vaccines and antiviral drugs in pandemic preparedness Emerg Infect Dis 12 55 60
5. TC Germann K Kadau IM Longini Jr CA Macken 2006 Mitigation strategies for pandemic influenza in the United States Proc Natl Acad Sci U S A 103 5935 40
6. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature 2006 Available from: http://www.nature.com/nature/journal/vaop/ncurrent/full/nature04795.html
7. AS Lipatov EA Govorkova RJ Webby H Ozaki M Peiris Y Guan 2004 Influenza: emergence and control J Virol 78 8951 9
8. WR Dowdle 2006 Influenza pandemic periodicity, virus recycling, and the art of risk assessment Emerg Infect Dis 12 34 9
9. DJ Smith 2006 Predictability and preparedness in influenza control Science 312 392 4
10. The World Health Organization Global Influenza Program Surveillance Network 2005 Evolution of H5N1 avian influenza viruses in Asia Emerg Infect Dis 11 1515 21
11. GA Poland 2006 Vaccines against avian influenza - a race against time N Engl J Med 354 1411 3
12. JM Wood 2001 Developing vaccines against pandemic influenza Philos Trans R Soc Lond B Biol Sci 356 1953 60
13. World Health Organization 2005 Influenza vaccines: WHO position paper Wkly Epidemiol Rec 80 279 88
14. DS Fedson 2003 Pandemic influenza and the global vaccine supply Clin Infect Dis 36 1552 61
15. I Stephenson KG Nicholson JM Wood MC Zambon JM Katz 2004 Confronting the avian influenza threat: vaccine development for a potential pandemic Lancet Infect Dis 4 499 509
16. JJ Treanor JD Campbell KM Zangwill T Rowe M Wolff 2006 Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine N Engl J Med 354 1343 51
17. KG Nicholson AE Colegate A Podda I Stephenson J Wood E Ypma 2001 Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza Lancet 357 1937 43
18. FG Hayden 2001 Perspectives on antiviral use during pandemic influenza Philos Trans R Soc Lond B Biol Sci 356 1877 84
19. H Suzuki R Saito H Masuda H Oshitani M Sato I Sato 2003 Emergence of amantadine-resistant influenza A viruses: epidemiological study J Infect Chemother 9 195 200
20. RA Bright MJ Medina X Xu G Perez-Oronoz TR Wallis XM Davis 2005 Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern Lancet 366 1175 81
21. T Jefferson V Demicheli D Rivetti M Jones C Di Pietrantonj A Rivetti 2006 Antivirals for influenza in healthy adults: systematic review Lancet 367 303 13
22. QM Le M Kiso K Someya YT Sakai TH Nguyen KH Nguyen 2005 Avian flu: isolation of drug-resistant H5N1 virus Nature 437 1108
23. MD de Jong TT Tran HK Truong MH Vo GJ Smith VC Nguyen 2005 Oseltamivir resistance during treatment of influenza A (H5N1) infection N Engl J Med 353 2667 72
24. The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5 2005 Avian influenza A (H5N1) infection in humans N Engl J Med 353 1374 85
25. HL Yen AS Monto RG Webster EA Govorkova 2005 Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice J Infect Dis 192 665 72
26. DM Bell 2006 Non-pharmaceutical interventions for pandemic influenza, national and community measures Emerg Infect Dis 12 88 94
27. DM Bell 2006 Non-pharmaceutical interventions for pandemic influenza, international measures Emerg Infect Dis 12 81 7
28. T Day A Park N Madras A Gumel J Wu 2006 When is quarantine a useful control strategy for emerging infectious diseases? Am J Epidemiol 163 479 85
29. Anonymous 2003 Use of quarantine to prevent transmission of severe acute respiratory syndrome - Taiwan, 2003 MMWR Morb Mortal Wkly Rep 52 680 3
30. S Riley C Fraser CA Donnelly AC Ghani LJ Abu-Raddad AJ Hedley 2003 Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions Science 300 1961 6
31. C Fraser S Riley RM Anderson NM Ferguson 2004 Factors that make an infectious disease outbreak controllable Proc Natl Acad Sci U S A 101 6146 51
32. L Gostin 2006 Public health strategies for pandemic influenza ethics and the law JAMA 295 1700 4
33. L Hawryluck WL Gold S Robinson S Pogorski S Galea R Styra 2004 SARS control and psychological effects of quarantine, Toronto Canada Emerg Infect Dis 10 1206 12
34. JT Lau X Yang HY Tsui E Pang 2004 SARS related preventive and risk behaviours practised by Hong Kong-mainland China cross border travellers during the outbreak of the SARS epidemic in Hong Kong J Epidemiol Community Health 58 988 96
35. A Heymann G Chodick B Reichman E Kokia J Laufer 2004 Influence of school closure on the incidence of viral respiratory diseases among children and on health care utilization Pediatr Infect Dis J 23 675 7
36. SP Luby M Agboatwalla DR Feikin J Painter W Billhimer A Altaf 2005 Effect of handwashing on child health: a randomised controlled trial Lancet 366 225 33
37. MA Ryan RS Christian J Wohlrabe 2001 Handwashing and respiratory illness among young adults in military training Am J Prev Med 21 79 83
38. B Bean BM Moore B Sterner LR Peterson DN Gerding HH Balfour Jr 1982 Survival of influenza viruses on environmental surfaces J Infect Dis 146 47 51
39. B Luckingham 1984 To mask or not to mask: a note on the 1918 Spanish influenza epidemic in Tucson J Ariz Hist 25 191 204
40. J Wu F Xu W Zhou DR Feikin CY Lin X He 2004 Risk factors for SARS among persons without known contact with SARS patients, Beijing China Emerg Infect Dis 10 210 6
41. JT Lau H Tsui M Lau X Yang 2004 SARS transmission risk factors and prevention in Hong Kong Emerg Infect Dis 10 587 92
42. JY Lo TH Tsang YH Leung EY Yeung T Wu WW Lim 2005 Respiratory infections during SARS outbreak, Hong Kong, 2003 Emerg Infect Dis 11 1738 41
43. CB Bridges MJ Kuehnert CB Hall 2003 Transmission of influenza: implications for control in health care settings Clin Infect Dis 37 1094 101
44. CD Salgado BM Farr KK Hall FG Hayden 2002 Influenza in the acute hospital setting Lancet Infect Dis 2 145 55
45. DA Goldmann 2000 Transmission of viral respiratory infections in the home Pediatr Infect Dis J 19 10 Suppl S97 102
46. DM Bell 2004 Public health interventions and SARS spread, 2003 Emerg Infect Dis 10 1900 6
47. BS Cooper RJ Pitman WJ Edmunds NJ Gay 2006 Delaying the international spread of pandemic influenza PLoS Med 3 e212